Evaluation of a Health Education Program for Type 2 Diabetes Patients (EDUCA-DM)
Retinopathy, Diabetic
About this trial
This is an interventional prevention trial for Retinopathy, Diabetic
Eligibility Criteria
Inclusion Criteria: Subjects with type 2 DM participating in STAR (CEC/008/16) and EYEMARKER (CEC/009/17) Higher risk patients through the RetinaRisk ® app ≥ 3% Age ≥50 years Body mass index (IMC) ≥ 25; Glycated hemoglobin (HbA1C): ≥6.5%; (7) Arterial hypertension (HTA): ≥ 139-89 (8) Presence of mild to moderate NPDR with presence of visible retina lesions (microaneurysms, hemorrhages, hard exudates and soft exudates) Subjects capable of understanding the information about the study and giving their informed consent to enter the study. Subjects willing and able to comply with the study. Exclusion Criteria: Type 1 DM Moderately Severe NPDR; Presence of DME or PDR Other retinal vascular diseases than DR
Sites / Locations
- AIBILI-CEC (AIBILI- Clinical Trials Centre)
Arms of the Study
Arm 1
Other
Health education sessions for type 2 diabetic patients
Patients will be pre-selected according to their risk of developing DR. It will be done through the Retina Risk® application. Will be invited to participate and followed. Retrospective and prospective data will be collected on medical and ophthalmological history (HbA1c value, if performed. 3 questionnaires will be carried out: DM disease, self-care, and emotional state, before and after awareness intervention about self-care through educational sessions in areas of greatest need (physical activity, nutrition, mental health, and self-care). The impact of the previously described sessions on the patients' health status will be assessed using 2 methods: By telephone and by physical examination. Repetition of the 3 questionnaires applied in V1. The Interventions will be made, through information sessions on the topics: mental health, nutrition, physical exercise, and care that diabetics must take to take care of their body.